GeneGo to Use NCI SBIR Grant to Work with FDA on Cancer and Nutrition Studies | GenomeWeb
NEW YORK (GenomeWeb News) – GeneGo said today that it has received a grant of an undisclosed sum from the National Cancer Institute that it will use to work with the US Food and Drug Administration to develop technology for studying nutrition and cancer causes and prevention.
 
The company said it will use the one-year Phase I Small Business Innovation Research grant to collaborate with Jim Kaput, director of FDA’s Personalized Nutrition and Medicine program.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.